ICU · Renal/Metabolic
Acute severe hyperkalaemia: emergency management algorithm
Also known as Hyperkalaemia · High potassium · Potassium emergency · Hyperkalemia
Hyperkalaemia: UKKA/ERC threshold K+ ≥5.5 mmol/L (mild 5.5–5.9, moderate 6.0–6.4, severe ≥6.5); some reviews use >5.0. SEVERE (≥6.5 or ECG changes): life-threatening arrhythmia. Causes: AKI/CKD, rhabdomyolysis, tumour lysis, drugs (ACEi/ARB, K-sparing diuretics, TMP-SMX, heparin), Addison's, acidosis. ECG changes may be absent (only 55% of a 344-patient cohort had any change). Management: (1) STABILISE membrane with IV calcium (UKKA equivalent 6.8 mmol Ca2+). (2) SHIFT (insulin/glucose, salbutamol). (3) REMOVE (diuretics, binders, dialysis).
Checked against its sources on 3 Sept 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- ECG changes (peaked T, wide QRS, sine wave) → IV calcium IMMEDIATELY (UKKA equivalent 6.8 mmol Ca2+)
- K+ ≥6.5 mmol/L → emergency, even without ECG changes
- Sine wave → pre-arrest, calcium + insulin/glucose + prepare for dialysis
- Cardiac arrest with hyperkalaemia → calcium chloride + insulin/glucose + sodium bicarbonate during CPR
- BRASH syndrome (bradycardia + renal failure + AV blockade + shock + hyperkalaemia) — a self-perpetuating loop driven by AV nodal blockers + hyperkalaemia
- Hypoglycaemia after insulin/glucose — monitor 4–6 h (Moussavi) and up to 12 h (UKKA)
Meet the patient
A 72-year-old with CKD stage 4, on perindopril, spironolactone and trimethoprim-sulfamethoxazole for a urinary tract infection, arrives weak and presyncopal. Heart rate 44, BP 92/58. The venous gas reads K+ 7.4 mmol/L, pH 7.28, bicarbonate 16. The ECG shows a wide QRS at 134 ms with peaked, tented T waves in V2-V4 and absent P waves.[16][15]
This is the prototypical ICU stem, and it asks the one question every paper repeats: what is the first drug, and why does the order matter? The answer — calcium before anything that lowers potassium — is the most testable fact in the topic, and the one juniors invert.[3]
References27ShowHide
- [1]Clase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Kidney Int, 2020.PMID 31706619
- [2]Palmer BF, Carrero JJ, Clegg DJ. Clinical Management of Hyperkalemia Mayo Clin Proc, 2021.PMID 33160639
- [3]Long B, Warix JR, Koyfman A. Controversies in Management of Hyperkalemia J Emerg Med, 2018.PMID 29731287
- [4]Moussavi K, Fitter S, Gabrielson SW. Management of Hyperkalemia With Insulin and Glucose: Pearls for the Emergency Clinician J Emerg Med, 2019.PMID 31084947
- [5]Harel Z, Kamel KS. Optimal Dose and Method of Administration of Intravenous Insulin in the Management of Emergency Hyperkalemia: A Systematic Review PLoS One, 2016.PMID 27148740
- [6]Farkas JD, Long B, Koyfman A. BRASH Syndrome: Bradycardia, Renal Failure, AV Blockade, Shock, and Hyperkalemia J Emerg Med, 2020.PMID 32565167
- [7]Eggertsen MA, Munch Johannsen C, Kovacevic A, et al. Sodium Bicarbonate and Calcium Chloride for the Treatment of Hyperkalemia-Induced Cardiac Arrest: A Randomized, Blinded, Placebo-Controlled Animal Study Crit Care Med, 2024.PMID 37921685
- [8]Allon M, Shanklin N. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol Am J Kidney Dis, 1996.PMID 8840939
- [9]Roger SD, Lavin PT, Lerma EV, et al. Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study Nephrol Dial Transplant, 2021.PMID 32030422
- [10]Pitt B, Bakris GL, Weir MR, et al. Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DN ESC Heart Fail, 2018.PMID 29767459
- [11]Geldermann N, Dzimiera J, Fischer H, et al. Acute hyperkalaemia in emergency care: evidence-based approaches Emerg Med J, 2026.PMID 41506858
- [12]Sumida K, Biruete A, Kistler BM, et al. New Insights Into Dietary Approaches to Potassium Management in Chronic Kidney Disease J Ren Nutr, 2023.PMID 37610407
- [13]Batterink J, Cessford TA, Taylor RA. Pharmacological interventions for the acute management of hyperkalaemia in adults Cochrane Database Syst Rev, 2015.PMID 35658162
- [14]Hollander-Rodriguez JC, Calvert JF. Hyperkalemia Am Fam Physician, 2006.PMID 16445274
- [15]Kim MJ, Valerio C, Knobloch GK. Potassium Disorders: Hypokalemia and Hyperkalemia Am Fam Physician, 2023.PMID 36689973
- [16]Ben Salem C, Badreddine A, Fathallah N, et al. Drug-induced hyperkalemia Drug Saf, 2014.PMID 25047526
- [17]Levine M, Nikkanen H, Pallin DJ. The effects of intravenous calcium in patients with digoxin toxicity J Emerg Med, 2011.PMID 19201134
- [18]Graafsma J, Cimic N, Dijkman M, et al. Digoxin toxicity with therapeutic serum digoxin concentrations Toxicol Rep, 2025.PMID 40687894
- [19]Meng QH, Wagar EA. Pseudohyperkalemia: A new twist on an old phenomenon Crit Rev Clin Lab Sci, 2015.PMID 25319088
- [20]Ssenabulya FR, Chothia MY. Association of hyperkalaemia with electrocardiographic changes at a tertiary centre in South Africa J Coll Med S Afr, 2025.PMID 40951599
- [21]Littmann L, Gibbs MA. Electrocardiographic manifestations of severe hyperkalemia J Electrocardiol, 2018.PMID 30177318
- [22]Martyn JAJ, Richtsfeld M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms Anesthesiology, 2006.PMID 16394702
- [23]Dineen R, Thompson CJ, Sherlock M. Adrenal crisis: prevention and management in adult patients Ther Adv Endocrinol Metab, 2019.PMID 31223468
- [24]Barski L, Golbets E, Jotkowitz A, Schwarzfuchs D. Management of diabetic ketoacidosis Eur J Intern Med, 2023.PMID 37419787
- [25]Sorensen MV, Matos JE, Praetorius HA, Leipziger J. Colonic potassium handling Pflugers Arch, 2010.PMID 20143237
- [26]Diercks DB, Shumaik GM, Harrigan RA, et al. Electrocardiographic manifestations: electrolyte abnormalities J Emerg Med, 2004.PMID 15261358
- [27]Alfonzo A, Harrison A, Baines R, Chu A, Mann S, MacRury M. Treatment of Acute Hyperkalaemia in Adults Renal Association / UK Kidney Association (final version June 2020; July 2020 pagination; hosted as July 2022 V2_0 PDF), 2020.Source